September 19, 2023 Matt Harbaugh Peptilogics Reports Positive 180-Day Top-Line Interim Data From Phase 1B September 19, 2023 Matt Harbaugh Peptilogics Reports Positive 180-Day Top-Line Interim Data From Phase 1B Trial of PLG0206 in Patients With Periprosthetic Joint Infection (PJI) Matt Harbaugh
